Indapta Therapeutics
Biotechnology
United States
22 employees
- Employees
- 22
- Contacts
- 3
- Emails
- 3
- Phones
- 1
Indapta Therapeutics Overview
- Headquarters
- United States
- Website
- indapta.com
- Industry
- Biotechnology
- Employees
- 22
- Funding
- 22.5M
About Indapta Therapeutics
Indapta's allogeneic g-NK cells have highly potent ADCC activity, making them the ideal therapy to combine with IgG1 monoclonal antibodies, ADCs, or innate immune cell engager molecules.
Indapta Therapeutics Contact Details
- People in AeroLeads
- 4
- With contact data
- 3
- Email contacts
- 3
- 75.0% coverage
- Phone contacts
- 1
- 25.0% coverage
Indapta Therapeutics Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Jim Weiss | Founder & Chairman, Real Chemistry |
View
|
|
| Robert Sikorski Md, Phd | Managing Director at Woodside Way | South San Francisco, California, United States |
Email
|
| Fabio Pucci | Biotech Investor at Leaps by Bayer | Boston, Massachusetts, United States |
Email
|
| Ronald Martell | CEO & President Jasper Therapeutics | San Francisco, California, United States |
Email
Phone
|
Employees by Management Level
Executive
2 profiles
Director
1 profile
Individual contributor
1 profile
Compare Similar Companies to Indapta Therapeutics
Andelyn Biosciences
Biotechnology Research
Sangamo Therapeutics, Inc.
Biotechnology Research
Umoja Biopharma
Biotechnology Research
Atara Biotherapeutics
Biotechnology Research
Tune Therapeutics
Biotechnology
Outpace Bio
Biotechnology Research
Tr1X
Biotechnology Research
Akamis Bio
Biotechnology Research
Shinobi Therapeutics
Biotechnology Research
Citryll
Biotechnology Research